Mesenchymal Stem Cell-Derived Exosomes in Anti-NET Therapy: Mechanisms, Challenges, and Future Perspectives

Area of Science:

• Immunology
• Cell Biology
• Therapeutics

Background:

• Neutrophils are crucial innate immune cells.
• Neutrophril extracellular traps (NETs) are involved in host defense but also disease pathogenesis.
• Targeting NETs is a potential therapeutic strategy.

Purpose of the Study:

• To review the progress of mesenchymal stem cell (MSC)-derived exosome-based therapies targeting NETs.
• To discuss strategies for enhancing the therapeutic application of these exosomes.

Main Methods:

• Review of current research on MSC-derived exosomes and their anti-NET mechanisms.
• Analysis of exosome properties, including miRNA and CD59 delivery.
• Discussion of challenges and future directions in exosome-based therapy.

Main Results:

• MSC-derived exosomes effectively modulate NET formation.
• Exosomes inhibit NET release by blocking signaling pathways and protecting neutrophil mitochondria.
• Exosomes offer advantages like lower immunogenicity and higher stability compared to MSCs.

Conclusions:

• MSC-derived exosomes represent a promising therapeutic approach for NET-related diseases.
• Further research is needed to overcome challenges like low yield and targeting efficiency.
• Optimizing exosome delivery and function can enhance their clinical application.